In December 2019, new PhD student Nathan Wu joined the group. He is working on the project 'Bionanotechnology-enabled monitoring of disease progression during cancer treatment', co-funded by the Scottish Research Partnership in Engineering and biopharmaceutical company Celgene. We wish him every success with his research.
